Clark S S, Liang Y
Department of Human Oncology, University of Wisconsin, School of Medicine, Madison.
Leukemia. 1995 Jan;9(1):165-74.
Leukemias induced with the v-abl or BCR/ABL oncogene undergo a process of tumor progression which suggests that the ABL oncogene is required but not sufficient for full transformation. In order to identify cellular changes that correlate with progression to full transformation in v-abl transformed lymphoblasts Abelson virus (A-MuLV)-infected murine bone marrow was plated over a pre-established stromal feeder layer. Shortly after A-MuLV infection, transformed lymphoblasts were poorly oncogenic, but over time, progressed in a stepwide manner to a more oncogenic state. The transformants first acquired the ability to grow efficiently in agar, but only over the feeder layer. They next progressed to efficient feeder-independent growth in liquid culture, and then to efficient feeder-independent growth in soft agar. Cell lines that reached the advanced stage of feeder-independent agar growth showed increased detection by antiphosphotyrosine Western blot of the GAP-associated p62 phosphoprotein as well as of a 55 kDa phosphoprotein while detection of the P160 v-abl phosphoprotein remained constant throughout all stages of progression. Although the identity of the p55 phosphoprotein and the mechanism by which detection of p55 and p62 phosphoproteins change on the Western blots during tumor progression are unknown, the data demonstrate that these changes strongly correlate with the stage of progression of v-abl-transformed cells and raise the possibility that these changes may play a role in tumor progression in this model.
由v-abl或BCR/ABL致癌基因诱导产生的白血病会经历肿瘤进展过程,这表明ABL致癌基因对于完全转化是必需的,但并不充分。为了确定与v-abl转化的淋巴母细胞向完全转化进展相关的细胞变化,将感染Abelson病毒(A-MuLV)的小鼠骨髓接种在预先建立的基质饲养层上。在A-MuLV感染后不久,转化的淋巴母细胞致癌性较弱,但随着时间的推移,会逐步进展到更具致癌性的状态。转化体首先获得了在琼脂中高效生长的能力,但仅在饲养层上。接下来,它们进展到在液体培养中高效的不依赖饲养层生长,然后进展到在软琼脂中高效的不依赖饲养层生长。达到不依赖饲养层琼脂生长晚期阶段的细胞系,通过抗磷酸酪氨酸蛋白质免疫印迹法检测到与GAP相关的p62磷蛋白以及一种55 kDa磷蛋白的信号增加,而在整个进展的所有阶段,P160 v-abl磷蛋白的检测保持恒定。尽管p55磷蛋白的身份以及在肿瘤进展过程中蛋白质免疫印迹法检测p55和p62磷蛋白变化的机制尚不清楚,但数据表明这些变化与v-abl转化细胞的进展阶段密切相关,并增加了这些变化可能在该模型的肿瘤进展中起作用的可能性。